PDCD1 and psoriasis: Based on his rash onset with atezolizumab and rapid recrudescence with PD-1 inhibitor pembrolizumab, classic cutaneous morphology and psoriatic arthritis diagnosis, he was diagnosed with PD-L1/PD-1-induced psoriasis/psoriatic arthritis.